Latest News

The research is clear on when you should claim Social Security benefits, and making the wrong choice could come at a big cost to your lifetime income.

You can rarely go wrong with blue chip dividend stocks.

Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s latest update. Speaking at a Bank of America healthcare conference, Lewis said the company intended

This technology isn't ready to go mainstream yet, but getting portfolio exposure to it before that happens could prove a profitable strategy.

Nuclear energy could grow into a $10 trillion industry in the next 25 years. For investors who are bullish on nuclear, these two stocks are absolute buys.

Anthropic to brief global financial authorities on AI-identified cyber risks as regulators assess vulnerabilities and develop AI safety guidelines.

Mark Kelly warns AI will reshape the U.S. economy, security and daily life, urging commonsense guardrails to protect privacy.